Labshake search
Citations for Stemcell Technologies :
201 - 250 of 1677 citations for Cow Casein Kinase II Subunit Alpha 2 CSNK2A2 ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: Untreated 2153L and 2151R tumors were dissociated in 1 mg/ml Collagenase A for 2 hrs at 37°C and TAMs were separated using EasySep™ Mouse F4/80 Positive Selection Kit (STEMCELL technologies, #100-0659) following manufacture’s protocol ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... The resulting CD34+ HSPCs were cultured in HSPC media: StemSpan SFEM II (STEMCELL Technologies Inc.) supplemented with 1% penicillin/streptomycin/amphotericin B and SFT cytokines ...
-
bioRxiv - Immunology 2020Quote: ... CD34+ cells were first thawed and rested for 48 h in SFEM II (StemCell Technologies) with 75 nM StemRegenin 1 (StemCell Technologies) ...
-
bioRxiv - Cell Biology 2023Quote: Thawed CD34+ cells were cultured in StemSpan SFEM II serum-free medium (Stem cell technologies) supplemented with recombinant cytokines (Peprotech Asia) ...
-
bioRxiv - Bioengineering 2021Quote: ... 2 μg/ml Heparin (STEMCELL Technologies), 20 ng/ml bFGF (Millipore) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 2 μg/ml heparin (StemCell Technologies), epidermal growth factor (EGF ...
-
bioRxiv - Neuroscience 2020Quote: ... 2% NeuroCult SM1 supplement (STEMCELL Technologies), 2 mM GlutaMax.
-
bioRxiv - Developmental Biology 2020Quote: ... 10ng/mL FGF-2 (StemCell Technology), and 5nM Rock inhibitor ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µM SB431542 (StemCell Technologies). Cells were maintained in NbM for 6 days after which they were passaged with 1 U/mL Dispase (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 2% SM1 (Stemcell Technologies, Vancouver, Canada), and 5 μM cytosine β-d-arabinofuranoside (AraC ...
-
bioRxiv - Cancer Biology 2023Quote: ... 2 μg/ml heparin (Stemcell Technologies), 50 units/ml penicillin ...
-
bioRxiv - Neuroscience 2023Quote: ... B27 (2%v/v, Stemcell technologies), N2 (0.5%v/v ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (05711, Stemcell technologies), 1% N2 Supplement (Thermo Scientific ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of 1 μg/L of human interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Genetics 2019Quote: ... The electroporated cells were resuspended with Stemspan II media with CC100 cytokine cocktail (Stem Cell Technologies). Two guides targeting GFI1B coding regions (sgRNA1 ...
-
bioRxiv - Bioengineering 2020Quote: ... Cells were thawed the day of use and kept in StemSpan SFEM II media (StemCell Technologies) with CD34 supplement (StemCell Technologies ...
-
bioRxiv - Cell Biology 2021Quote: ... CD34+ cells (1 × 105/mL) were suspended in serum-free expansion medium II (Stem Cell Technologies) with 50 ng/mL stem cell factor (PeproTech ...
-
bioRxiv - Bioengineering 2021Quote: ... The cryopreserved AML cells were thawed by adding dropwise StemSpan SFEM II medium (StemCell Technologies, 09605) supplemented with 1 % penicillin/streptomycin (P/S ...
-
bioRxiv - Bioengineering 2021Quote: CD34+ leukemic blasts were cultured in StemSpan™ SFEM II serum-free medium (STEMCELL Technologies, 09605) supplemented with the StemSpan™ CD34+ Expansion supplement (STEMCELL Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... which comprised of StemSpan SFEM II medium with Stemspan CD34+ supplement (STEMCELL Technologies, Inc., Vancouver, Canada). Cells were maintained for 4 days at 5% CO2 at 37°C before further use.
-
bioRxiv - Cell Biology 2023Quote: ... All human CD34+ HSPCs were cultured in StemSpan SFEM II medium (STEMCELL Technologies, Cambridge, MA, USA) supplemented with stem cell factor (SCF ...
-
bioRxiv - Genomics 2020Quote: ... with 2 mM L-Glutamine (Stemcell Technologies), 1x 2-Mercaptoethanol (Millipore) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 µM XAV939 (StemCell Technologies, 72674). TPM was changed every day from day 3 to day 7 ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% SM1 (Stemcell Technologies; 05792), 5 mM L-Glutamine (Stemcell Technologies ...
-
bioRxiv - Genetics 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 2 mM EDTA (Stemcell Technologies) and pooled for antibody staining.
-
bioRxiv - Cell Biology 2022Quote: ... and 2% SM1 supplement (Stem Cell Technologies), and subsequently fed with astrocyte-conditioned BrainPhys media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... supplemented with 2% SM1 (StemCell Technologies #05711), 40 μg/mL gentamycin and 2.5 μg/mL Amphotericin B medium ...
-
bioRxiv - Pathology 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Molecular Biology 2022Quote: ... & 300 IU/mL IL-2 (STEMCELL Technologies). T cells were seeded at 2 × 106 cells/mL (typically 10×106 cells per well of a 6-well plate ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... heparin solution (2 mg/mL, STEMCELL Technologies), recombinant bFGF (20 ng/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Cancer Biology 2023Quote: ... heparin (2 mg/mL, STEMCELL Technologies 07980), 1% penicillin/streptomycin ...
-
bioRxiv - Cell Biology 2023Quote: ... and 2.5µM of IWP-2(Stemcell Technologies). Rudibaugh2 organoid media was supplemented with 100ng/mL SHH(VWR ...
-
bioRxiv - Cell Biology 2024Quote: ... 2 mg/mL DNase I (STEMCELL Technologies), and 5 mg/mL (adult ...
-
bioRxiv - Biochemistry 2023Quote: ... 2 μg/ml heparin (Stem Cell Technologies), 20 ng/ml EGF-1 (Cell Guidance ...
-
bioRxiv - Developmental Biology 2024Quote: ... in APEL 2 base medium (Stemcell Technologies). On day 3 ...
-
bioRxiv - Cancer Biology 2024Quote: ... 2 μg/ml heparin (Stemcell Technologies, 07980), and penicillin-streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 2% SM1 (STEMCELL Technologies, 05792), 5 mM L-glutamine (STEMCELL Technologies ...
-
bioRxiv - Microbiology 2020Quote: CD34+ HPCs from 3 independent donors were thawed and plated in StemSpan SFEM II media (Stemcell Technologies) containing 10% BIT serum substitute ...
-
Efficient Methods for Target Gene Manipulation in Haematopoietic Stem Cell Derived Human NeutrophilsbioRxiv - Cell Biology 2023Quote: ... medium was changed to SFEM II containing 10ng/mL recombinant human granulocyte colony stimulating factor (StemCell Technologies) and maintained in this medium until day 20 ...
-
bioRxiv - Cancer Biology 2023Quote: ... The human MLL-AF9-transduced cells were cultured in StemSpan SFEM II medium (#ST-09655, STEMCELL Technologies) containing 1% penicillin– streptomycin together with 10 ng/ml rhSCF (#255-SC ...
-
bioRxiv - Molecular Biology 2024Quote: ... HSPC: StemSpan™ SFEM II supplemented with StemSpan™ CD34+ Expansion Supplement (10X) (StemCell Technologies, Catalog # 09720). IPSC ...
-
bioRxiv - Neuroscience 2019Quote: ... with medium changes every 2-3 days and passages 1-2 times per week using ReLeSR (Stem Cell Technologies). Heteroplasmy levels were regularly measured to insure they were retained across passage numbers ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 H3.1-K27M (GSC3, GSC4) cellular models were grown in NeurocultTM medium supplemented with heparin (2 μg/mL, Stemcell Technologies), EGF/FGF (20ng/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD34+ cells enriched from CMML patients or healthy donors were cultured in StemSpan SFEM II medium (STEMCELL Technologies) supplemented with 10% fetal bovine serum (FBS) ...
-
Efficient Methods for Target Gene Manipulation in Haematopoietic Stem Cell Derived Human NeutrophilsbioRxiv - Cell Biology 2023Quote: ... Cells were plated at a minimum density of 5 × 105 cells/mL in SFEM II medium (StemCell Technologies) with StemSpanTM CD34+ Expansion Supplement (StemCell Technologies) ...
-
bioRxiv - Molecular Biology 2023Quote: ... CD34+ HSPCs were cultured at 1×105 cells/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies) or Good Manufacturing Practice Stem Cell Growth Medium (SCGM ...
-
bioRxiv - Bioengineering 2022Quote: ... and cultured in StemSpan SFEM II medium supplemented with StemSpan™ CD34+ Expansion Supplement and UM729 (StemCell Technologies). HSPCs were ready for electroporation after 4-5 days in culture ...